These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of invasive electrophysiological procedures and gender: are males and females the same? Santangeli P; di Biase L; Pelargonio G; Natale A J Cardiovasc Electrophysiol; 2011 May; 22(5):605-12. PubMed ID: 20958833 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
4. Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure. Sengupta J; Abdelhadi R Curr Opin Cardiol; 2013 May; 28(3):337-43. PubMed ID: 23549236 [TBL] [Abstract][Full Text] [Related]
5. Sinus rhythm restoration by catheter ablation in patients with long-lasting atrial fibrillation and congestive heart failure: impact of the left ventricular ejection fraction improvement on the implantable cardioverter defibrillator insertion indication. Bortone A; Boveda S; Pasquié JL; Pujadas-Berthault P; Marijon E; Appetiti A; Albenque JP Europace; 2009 Aug; 11(8):1018-23. PubMed ID: 19556251 [TBL] [Abstract][Full Text] [Related]
6. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Schuler PK; Herrey A; Wade A; Brooks R; Peebles D; Lambiase P; Walker F Europace; 2012 Dec; 14(12):1740-5. PubMed ID: 22744770 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter-defibrillator use and benefit in women. Lampert R Cardiol Rev; 2007; 15(6):298-303. PubMed ID: 18090065 [TBL] [Abstract][Full Text] [Related]
9. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
10. [Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?]. Tanner H; Hindricks G; Kottkamp H Herz; 2005 Nov; 30(7):613-8. PubMed ID: 16333587 [TBL] [Abstract][Full Text] [Related]
11. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S; Kasanuki H J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174 [TBL] [Abstract][Full Text] [Related]
12. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108 [TBL] [Abstract][Full Text] [Related]
13. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon. Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624 [TBL] [Abstract][Full Text] [Related]